Add Company
Join Now

Auron Therapeutics Revenue and Competitors

License our Company Data API

Wellesley,

Location

$90M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Auron Therapeutics's estimated annual revenue is currently $2.6M per year.(i)
  • Auron Therapeutics's estimated revenue per employee is $77,500
  • Auron Therapeutics's total funding is $90M.

Employee Data

  • Auron Therapeutics has 34 Employees.(i)
  • Auron Therapeutics grew their employee count by 0% last year.

Auron Therapeutics's People

NameTitleEmail/Phone
1
Founder, CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
VP, Clinical DevelopmentReveal Email/Phone
4
VP, CMCReveal Email/Phone
5
VP, Program Management & OperationsReveal Email/Phone
6
DirectorReveal Email/Phone
7
Director, Translational BiologyReveal Email/Phone
8
Director Medicinal ChemistryReveal Email/Phone
9
Chief Scientific OfficerReveal Email/Phone
10
Senior Director, Head R&D Strategy and OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Auron Therapeutics?

Auron Therapeutics aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. This transformation, called differentiation therapy, reactivates endogenous cellular programs to elicit tumor cell maturation and reprogram cancer tissue to a more normal phenotype.

keywords:N/A

$90M

Total Funding

34

Number of Employees

$2.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.4M3728%$45M
#2
$3.2M4014%N/A
#3
$7.3M403%N/A
#4
$10M418%N/A
#5
$8.9M418%N/A